Walleye Capital’s Idexx Laboratories IDXX Stock Holding History

Walleye Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$169K	Buy	300 +100	+50%	+$64.1K	﹤0.01%	3432
2025 Q4	$135K	Buy	+200	New	+$136K	﹤0.01%	3738
2025 Q3	–	Sell	-200	Closed	-$107K	–	4789
2025 Q2	$107K	Sell	200 -400	-67%	-$191K	﹤0.01%	3745
2025 Q1	$252K	Sell	600 -1,500	-71%	-$651K	﹤0.01%	3088
2024 Q4	$868K	Buy	2,100 +1,300	+163%	+$570K	﹤0.01%	2508
2024 Q3	$404K	Buy	800 +600	+300%	+$291K	﹤0.01%	3495
2024 Q2	$97.4K	Sell	200 -5,700	-97%	-$2.86M	﹤0.01%	4731
2024 Q1	$3.19M	Buy	5,900 +1,300	+28%	+$710K	0.01%	1649
2023 Q4	$2.55M	Sell	4,600 -5,600	-55%	-$2.63M	0.01%	1601
2023 Q3	$4.46M	Buy	10,200 +1,900	+23%	+$947K	0.01%	1116
2023 Q2	$4.17M	Buy	8,300 +8,200	+8,200%	+$3.93M	0.02%	849
2023 Q1	$50K	Buy	+100	New	+$47.9K	﹤0.01%	3207

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Walleye Capital's IDXX Position: Q1 2026 in Review

Walleye Capital reduced its Idexx Laboratories (IDXX) stake by 99% in Q1 2026, selling an estimated $8.5M and leaving 170 shares worth $95.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3692.

Walleye Capital first reported a position in IDXX in Q3 2021 and has held it in 12 quarters since. The position peaked at $15.6M in Q3 2024. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Walleye Capital held 170 shares of Idexx Laboratories worth $95.5K as of Q1 2026.
Walleye Capital sold 13,261 Idexx Laboratories shares in Q1 2026, an estimated $8.5M.
Idexx Laboratories made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #3692 holding.
Walleye Capital first reported a position in Idexx Laboratories in Q3 2021 and has held it in 12 quarters since.
Walleye Capital's Idexx Laboratories position peaked at $15.6M in Q3 2024.
1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.